Europe — EMA

Paclitaxel Accord Healthcare

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord Healthcare, is an antineoplastic presented as a sterile lyophilised powder for intravenous infusion use. It treats various solid tumours in adult oncology patients. GNH USA supplies Paclitaxel Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paclitaxel Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is used in oncology to target several solid tumour types through microtubule stabilization.

- Breast cancer: improves the overall response rate in combination with anthracycline‑based regimens. - Non‑small cell lung cancer: used as a first‑line treatment in combination with carboplatin. - Ovarian cancer: administered as maintenance therapy after surgical debulking and chemotherapy. - Cervical - -

Frequently asked questions

What +

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →